Essa Pharma (EPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2001 | 09-2000 | |
| Sales | 9,569 | 6,924 |
| Gross Profit | 9,569 | 6,924 |
| Operating Expenses | 5,506 | 4,835 |
| Operating Income | 4,063 | 2,089 |
| Interest Expense | 339 | 468 |
| Other Income | -21,880 | -24,577 |
| Pre-tax Income | -18,156 | -22,957 |
| Income Tax | 1,092 | N/A |
| Net Income Continuous | -19,248 | -22,957 |
| Net Income Discontinuous | N/A | -4,364 |
| Net Income | $-19,248 | $-27,320 |
| EBITDA(a) | $4,063 | $2,089 |